Insights

Allergies and asthma affect at least a quarter of the population. While often harmless, an increasing number of people suffer from severe allergies, resulting in more than 300.000 avoidable deaths per year. The WHO therefore declared allergy a major health problem of the 21st century. Currently, medical practitioners must pre-select very few allergens for in-vitro testing, based on prior anamnesis, which often results in false or incomplete diagnosis. There is no cost-efficient technology to improve the quality of diagnosis to an optimal level for patient-tailored and evidence-based treatment. The fast-growing segment of molecular diagnostic tests requires a new generation of assays and laboratory automation.

SWEETWOODS is a 43-million-euro joint pilot project that was recently granted 21 million euros in funding under the EU’s Horizon 2020 programme’s Bio-Based Industries financial instrument. Horizon 2020 is the biggest research and innovation programme in the world, supporting the development and introduction of new technologies. SWEETWOODS represented the only flagship project in the bioeconomy sector. The project is implemented through collaborative efforts of nine partner companies.

The possibilities of EU funding - case example of a success story.

EU Breakfast seminar: In just 1,5 hours, learn if your company could receive funding. At the same time you will learn how the SME instrument will change in the beginning of 2018 and how this will affect you. After the presentations, you have the possibility to discuss your potential for EU funding with experts and go through already existing project ideas.

Fast Track to Innovation is a funding instrument to boost close-to-market innovation projects.

EuroNanoForum 2017 event concluded on 23^rd of June in Valletta, Malta after three successful conference and exhibition days that attracted participants from over 40 countries and brought nanotechnology and open innovations in focus to strengthen the competitiveness of European manufacturing industries. In addition to being a co-organiser of the event, Spinverse took an active participant role as well, with Managing Director Laura Koponen, headlining a plenary session on "nanotechnologies for industrial success".

Spinverse has helped EuroPAT-MASIP project to secure funding from the Horizon 2020 programme within the “Electronics Components and Systems for European Leadership” (ECSEL) Joint Undertaking. The project ranked in the top 3 proposals submitted.

Spinverse has recently opened a new office in Berlin, in the renowned Factory Berlin HQ - first and largest startup campus in Germany, located at Rheinsberger Str. 76/77. This new presence offers excellent connections within the network of innovators consisting of freelancers, startups from all possible stages and verticals, established corporations as well as investors and leading influencers from politics, science and society. Members of the community include SoundCloud, Uber and Twitter among others.

Technology Industries of Finland organised a workshop that discussed the opportunities of EU's Horizon 2020 programme. Spinverse experts Markku Heino and Pirjo Pasanen were invited to give a talk on the topic. In their talk they emphasized that a company must first have a viable business idea, which can be developed into a 100 M€ business.